Sarah Gledhill
- Oncology top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Cancer Research top 10%
- Epidemiology
- Co-authors
- Amy MoserCindy LuongoWilliam F. DoveAlan R. ClarkeAH WyllieBird CcA S KrajewskiRuth F. Jarrett
- Topics
- Lymphoma Diagnosis and Treatment (4 papers)RNA modifications and cancer (3 papers)Viral-associated cancers and disorders (3 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Sarah Gledhill
14 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Oncology 597
- Molecular Biology 567
- Pathology and Forensic Medicine 404
- Cancer Research 161
- Epidemiology 153
Countries citing papers authored by Sarah Gledhill
This map shows the geographic impact of Sarah Gledhill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Gledhill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Gledhill more than expected).
Fields of papers citing papers by Sarah Gledhill
This network shows the impact of papers produced by Sarah Gledhill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Gledhill. The network helps show where Sarah Gledhill may publish in the future.
Co-authorship network of co-authors of Sarah Gledhill
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Gledhill. A scholar is included among the top collaborators of Sarah Gledhill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Gledhill. Sarah Gledhill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 73 | |
| 3 | 175 | |
| 4 | 67 | |
| 5 | 42 | |
| 6 | 4 | |
| 7 | 13 | |
| 8 | Loss of Apc+ in intestinal adenomas from Min mice. | 326 |
| 9 | p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. | 229 |
| 10 | 74 | |
| 11 | 9 | |
| 12 | 150 | |
| 13 | 16 | |
| 14 | Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. | 80 |
About Sarah Gledhill
Sarah Gledhill is a scholar working on Pathology and Forensic Medicine, Genetics and Developmental Neuroscience, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), RNA modifications and cancer (3 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (404 citations), Oncology (597 citations) and Biochemistry (136 citations). Sarah Gledhill has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Amy Moser, Cindy Luongo, William F. Dove, Alan R. Clarke, AH Wyllie, Bird Cc, A S Krajewski, Ruth F. Jarrett, RM Hope and Paul Targett‐Adams. Their work appears in journals such as Journal of Biological Chemistry, Oncogene and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.